104 related articles for article (PubMed ID: 22358104)
1. Effects of the histamine H3 receptor antagonist ABT-239 on acute and repeated nicotine locomotor responses in rats.
Miszkiel J; Kruk M; McCreary AC; Przegaliński E; Biała G; Filip M
Pharmacol Rep; 2011; 63(6):1553-9. PubMed ID: 22358104
[TBL] [Abstract][Full Text] [Related]
2. Effects of the histamine H₃ receptor antagonist ABT-239 on cognition and nicotine-induced memory enhancement in mice.
Kruk M; Miszkiel J; McCreary AC; Przegaliński E; Filip M; Biała G
Pharmacol Rep; 2012; 64(6):1316-25. PubMed ID: 23406742
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
[TBL] [Abstract][Full Text] [Related]
5. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonist.
Hudzik TJ; Basso A; Boyce-Rustay JM; Bracken W; Browman KE; Drescher K; Esbenshade TA; Loberg LI; Lynch JJ; Brioni JD
Psychopharmacology (Berl); 2013 Jul; 228(2):187-97. PubMed ID: 23455597
[TBL] [Abstract][Full Text] [Related]
7. Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice.
Bhowmik M; Saini N; Vohora D
Brain Res; 2014 Sep; 1581():129-40. PubMed ID: 24952295
[TBL] [Abstract][Full Text] [Related]
8. The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats.
Clemens KJ; Caillé S; Stinus L; Cador M
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1355-66. PubMed ID: 19366487
[TBL] [Abstract][Full Text] [Related]
9. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
Zaniewska M; McCreary AC; Stefański R; Przegaliński E; Filip M
Synapse; 2008 Dec; 62(12):935-9. PubMed ID: 18798299
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats.
Przegaliński E; Papla I; Siwanowicz J; Filip M
Eur Neuropsychopharmacol; 2004 May; 14(3):217-25. PubMed ID: 15056481
[TBL] [Abstract][Full Text] [Related]
11. Selective brain region activation by histamine H₃ receptor antagonist/inverse agonist ABT-239 enhances acetylcholine and histamine release and increases c-Fos expression.
Munari L; Provensi G; Passani MB; Blandina P
Neuropharmacology; 2013 Jul; 70():131-40. PubMed ID: 23380305
[TBL] [Abstract][Full Text] [Related]
12. 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.
Cowart M; Faghih R; Curtis MP; Gfesser GA; Bennani YL; Black LA; Pan L; Marsh KC; Sullivan JP; Esbenshade TA; Fox GB; Hancock AA
J Med Chem; 2005 Jan; 48(1):38-55. PubMed ID: 15634000
[TBL] [Abstract][Full Text] [Related]
13. Effects of the cognition-enhancing agent ABT-239 on fetal ethanol-induced deficits in dentate gyrus synaptic plasticity.
Varaschin RK; Akers KG; Rosenberg MJ; Hamilton DA; Savage DD
J Pharmacol Exp Ther; 2010 Jul; 334(1):191-8. PubMed ID: 20308329
[TBL] [Abstract][Full Text] [Related]
14. H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization.
Komater VA; Browman KE; Curzon P; Hancock AA; Decker MW; Fox GB
Psychopharmacology (Berl); 2003 Jun; 167(4):363-72. PubMed ID: 12682709
[TBL] [Abstract][Full Text] [Related]
15. In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease.
Bitner RS; Markosyan S; Nikkel AL; Brioni JD
Neuropharmacology; 2011; 60(2-3):460-6. PubMed ID: 21044639
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Sheppard B; Lehmann J; Cope ZA; Brown RW
Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
[TBL] [Abstract][Full Text] [Related]
17. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
[TBL] [Abstract][Full Text] [Related]
18. Melanin-concentrating hormone receptor antagonism differentially attenuates nicotine experience-dependent locomotor behavior in female and male rats.
Kuebler IRK; Liu Y; Bueno Álvarez BS; Huber NM; Jolton JA; Dasari R; Wakabayashi KT
Pharmacol Biochem Behav; 2023 Nov; 232():173649. PubMed ID: 37793486
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring.
Lacy RT; Brown RW; Morgan AJ; Mactutus CF; Harrod SB
Dev Neurosci; 2016; 38(3):171-185. PubMed ID: 27287203
[TBL] [Abstract][Full Text] [Related]
20. Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats.
Kayir H; Goktalay G; Yildirim M; Uzbay TI
Synapse; 2009 Jan; 63(1):15-21. PubMed ID: 18925656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
